41 A potential for combining the rapamycin derivative RAD001 (everolimus) with the EGF/ErbB2/VEGF receptor tyrosine kinase inhibitor AEE788 in human cancer

✍ Scribed by C. Stephan; S. Zumstein-Mecker; S. Gerboth; A. Boulay; S. Ruetz; N. Hynes; J. Baselga; H.A. Lane

• Book ID: 118621226
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 148 KB
• Volume: 2
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(04)80049-1